Immunomodulation of Skin Cancer.
Journal
International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791
Informations de publication
Date de publication:
21 Jun 2023
21 Jun 2023
Historique:
received:
03
05
2023
revised:
15
05
2023
accepted:
23
05
2023
medline:
17
7
2023
pubmed:
14
7
2023
entrez:
14
7
2023
Statut:
epublish
Résumé
Skin cancer represents a major public health issue with a tremendous cost to healthcare systems in the United States and worldwide [...].
Identifiants
pubmed: 37445639
pii: ijms241310462
doi: 10.3390/ijms241310462
pmc: PMC10341904
pii:
doi:
Types de publication
Editorial
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : NIAMS NIH HHS
ID : R01 AR071157
Pays : United States
Références
EMBO J. 2000 Mar 1;19(5):1157-66
pubmed: 10698956
Dermatol Pract Concept. 2017 Apr 30;7(2):1-6
pubmed: 28515985
Int J Mol Sci. 2023 Jan 18;24(3):
pubmed: 36768216
Int J Mol Sci. 2021 Jun 15;22(12):
pubmed: 34203771
Semin Oncol. 2020 Apr - Jun;47(2-3):117-124
pubmed: 32517874
J Cell Biochem. 2019 Mar;120(3):2756-2765
pubmed: 30270458
Int J Mol Sci. 2023 Feb 09;24(4):
pubmed: 36834917
Br J Dermatol. 2011 Nov;165(5):953-65
pubmed: 21729024
Tohoku J Exp Med. 1985 May;146(1):97-104
pubmed: 4024087
Cancer Res. 2012 Oct 15;72(20):5188-97
pubmed: 22836755
Int J Mol Sci. 2023 Jan 31;24(3):
pubmed: 36768978
Clin Cancer Res. 2002 Jul;8(7):2067-72
pubmed: 12114405
Int J Mol Sci. 2022 Jun 09;23(12):
pubmed: 35742905
Int J Mol Sci. 2022 Apr 06;23(7):
pubmed: 35409404
Int J Mol Sci. 2022 Feb 05;23(3):
pubmed: 35163747